Ling-Yan Cai

Model for end‐stage liver disease combined with serum prealbumin to predict the prognosis of patients with decompensated liver cirrhosis

Lan Zhong, Chi Chen, Fei Liu, 2010, Journal of digestive diseases.

Gut Microbial Profile in Asymptomatic Gallstones

W. Xie, Sen-tao Song, Xin Zeng, 2022, Frontiers in Microbiology.

Targeting p300/CBP Attenuates Hepatocellular Carcinoma Progression through Epigenetic Regulation of Metabolism

C. Luo, Shijie Chen, Bing Zhou, 2020, Cancer Research.

Targeting PRMT5 Activity Inhibits the Malignancy of Hepatocellular Carcinoma by Promoting the Transcription of HNF4α

Jingwei Shao, Jin Ding, Jifeng Feng, 2019, Theranostics.

The Role of Bone Morphogenetic Protein 9 in Nonalcoholic Fatty Liver Disease in Mice

Lan Zhong, Wei Wang, Xin Zeng, 2021, Frontiers in Pharmacology.